Search - tctmd.com

Displaying 21 - 40 of 411

Sort: Relevancy | Date

Presentation NY Valves 2025

Updates from the Sentinel Clinical Trial Program: PROTECTED TAVR and BHF PROTECT-TAVI Meta-Analysis

Presenter: Samir R. Kapadia

June 25, 2025

News Conference News EuroPCR 2025

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

Michael O'Riordan

May 21, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

Caitlin E. Cox

April 01, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Daily News

Embolic Protection Use During TAVI Declined After PROTECTED TAVR

Todd Neale

March 21, 2025

News Daily News

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Caitlin E. Cox

February 14, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

Todd Neale

October 31, 2024

Presentation TCT 2024

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Presenter: Jerry Lipinski

October 30, 2024

Presentation TCT 2024

TCT 316: Transradial/Brachial Carotid Artery Stenting With Proximal Cerebral Protection: A Feasible, Safe, and Effective First Line Strategy in 147 Consecutive Patients

Presenter: Piero Montorsi

October 29, 2024

Presentation TCT 2024

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Presenter: Samir Kapadia

October 29, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

Case: Evolving Stroke After TAVR

Presenter: Jason Bloom

October 28, 2024

Presentation TCT 2024

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

Presenter: Julia Seeger

October 28, 2024

Presentation TCT 2024

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Presenter: Aakriti Gupta

October 28, 2024

Presentation TCT 2024

The Role of Cerebral Embolic Protection in TAVR

Presenter: Samir Kapadia

October 28, 2024

Presentation TCT 2024

PROTEMBO Case presentation from the EU

Presenter: Stephan Haussig

October 28, 2024

Presentation TCT 2024

Importance of DW-MRI in Cerebral Embolic Protection Trials

Presenter: Alexandra Lansky

October 28, 2024

Advertisement

Updates from the Sentinel Clinical Trial Program: PROTECTED TAVR and BHF PROTECT-TAVI Meta-Analysis

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

TCTMD’s Top 10 Most Popular Stories for April 2025

TCTMD’s Top 10 Most Popular Stories for March 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Embolic Protection Use During TAVI Declined After PROTECTED TAVR

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Top Structural Heart News of 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

TCT 316: Transradial/Brachial Carotid Artery Stenting With Proximal Cerebral Protection: A Feasible, Safe, and Effective First Line Strategy in 147 Consecutive Patients

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

Case: Evolving Stroke After TAVR

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

The Role of Cerebral Embolic Protection in TAVR

PROTEMBO Case presentation from the EU

Importance of DW-MRI in Cerebral Embolic Protection Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content